Twenty-one patients with multidrug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa pneumonia were treated with nebulized polymyxin E (colistin). Overall clinical and microbiological ...
Purpose. The uses, dosing recommendations, benefits, and disadvantages of unlabeled drugs administered by nebulization are reviewed. Summary: Nebulization is gaining popularity as a treatment ...
Am J Health Syst Pharm. 2005;62(1):39-47. The inhaled dose most often administered in our study was 0.5 MU every eight hours. The fill volume for the nebulizer (Cirrus, Intersurgical, Wokingham, UK) ...
In the current era of increasing prevalence of multidrug-resistant gram-negative bacillary infections, previously shelved last-line therapies, such as the polymyxin agents colistin and polymyxin B, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback